Ronald Blue Trust, Inc. Absci Corp Transaction History

Ronald Blue Trust, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$1.58 - $3.41 $16,954 - $36,592	-10,731 Reduced 47.51%	11,854 $25,000
Q4 2022 Jan 17, 2023	SELL	$2.0 - $3.58 $14,306 - $25,607	-7,153 Reduced 24.05%	22,585 $71,000
Q3 2022 Oct 21, 2022	BUY	$2.95 - $4.83 $87,603 - $143,431	29,696 Added 70704.76%	29,738 $99,000
Q2 2022 Aug 09, 2022	BUY	$3.13 - $8.83 $131 - $370	42 New	42 $0

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $278M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.